Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Moschini

Showing results (71-80 of 560) with videos related to

Pageof 56
Sort By:
European Urology|December 5, 2018
Reply to Alba Fiorentino, Angelo Errico, and Marcello Scarcia's Letter to the Editor re: Marco Moschini, Emanuele Zaffuto, Pierre I. Karakiewicz, et al. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis. Eur Urol 2019;75:319-28: Radiation Therapy Versus Radical Prostatectomy: No Way Out Without a Randomized TrialMarco Moschini, Emanuele Zaffuto, Agostino Mattei, et al.
Translational Andrology and Urology|August 9, 2019
Adjuvant chemotherapy in bladder cancer patients with histological variants: time to change the approach?Luca Afferi, Stefania Zamboni, Philipp Baumeister, et al.
European Urology Oncology|September 25, 2021
Current Evidence and Future Perspectives in the Management of Nonmetastatic Upper Tract Urothelial CarcinomaLouis Lenfant, Alberto Breda, Evangelos Xylinas, et al.
World Journal of Urology|June 21, 2026
Comment to: "Repeat transurethral resection and contemporary oncologic outcomes among patients with non-muscle invasive urothelial carcinoma of the bladder"Pietro Scilipoti, Giuseppe Rosiello, Andrea Salonia, et al.
Current Opinion in Urology|July 20, 2022
Micropapillary bladder cancer: an evolving biologyChiara Lonati, Claudio Simeone, Nazareno Suardi, et al.
European Urology|December 4, 2018
Reply to Nicholas G. Zaorsky, Daniel E. Spratt, and Pierre Blanchard's Letter to the Editor re: Marco Moschini, Emanuele Zaffuto, Pierre I. Karakiewicz, et al. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis. Eur Urol 2019;75:319-28Marco Moschini, Emanuele Zaffuto, Agostino Mattei, et al.
Minerva Urology and Nephrology|December 1, 2021
Is there enough evidence available nowadays to suggest a paradigmatic shift in treatment of MIBC with perioperative systemic therapy administration?Francesco Del Giudice, David D'Andrea, Andrea Mari, et al.
Minerva Urology and Nephrology|January 11, 2023
Comment on "Neoadjuvant systemic therapy in patients undergoing nephroureterectomy for urothelial cancer: a multidisciplinary systematic review and critical analysis" on behalf of the Young Academic Urologists - Urothelial Cancer Working GroupLuca Afferi, Andrea Gallioli, Francesco Del Giudice, et al.
Urologia Internationalis|July 24, 2015
Does the Compliance to Intravesical BCG Differ between Common Clinical Practice and International Multicentric Trials?Vincenzo Serretta, Cristina Scalici Gesolfo, Vincenza Alonge, et al.
Current Urology Reports|August 13, 2015
What is the Need for Prostatic Biomarkers in Prostate Cancer Management?Martin Spahn, Silvan Boxler, Steven Joniau, et al.
Pageof 56

Showing results (71-80 of 560) with videos related to

Sort By:
Pageof 56
European Urology|December 5, 2018
Reply to Alba Fiorentino, Angelo Errico, and Marcello Scarcia's Letter to the Editor re: Marco Moschini, Emanuele Zaffuto, Pierre I. Karakiewicz, et al. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis. Eur Urol 2019;75:319-28: Radiation Therapy Versus Radical Prostatectomy: No Way Out Without a Randomized TrialMarco Moschini, Emanuele Zaffuto, Agostino Mattei, et al.
Translational Andrology and Urology|August 9, 2019
Adjuvant chemotherapy in bladder cancer patients with histological variants: time to change the approach?Luca Afferi, Stefania Zamboni, Philipp Baumeister, et al.
European Urology Oncology|September 25, 2021
Current Evidence and Future Perspectives in the Management of Nonmetastatic Upper Tract Urothelial CarcinomaLouis Lenfant, Alberto Breda, Evangelos Xylinas, et al.
World Journal of Urology|June 21, 2026
Comment to: "Repeat transurethral resection and contemporary oncologic outcomes among patients with non-muscle invasive urothelial carcinoma of the bladder"Pietro Scilipoti, Giuseppe Rosiello, Andrea Salonia, et al.
Current Opinion in Urology|July 20, 2022
Micropapillary bladder cancer: an evolving biologyChiara Lonati, Claudio Simeone, Nazareno Suardi, et al.
European Urology|December 4, 2018
Reply to Nicholas G. Zaorsky, Daniel E. Spratt, and Pierre Blanchard's Letter to the Editor re: Marco Moschini, Emanuele Zaffuto, Pierre I. Karakiewicz, et al. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis. Eur Urol 2019;75:319-28Marco Moschini, Emanuele Zaffuto, Agostino Mattei, et al.
Minerva Urology and Nephrology|December 1, 2021
Is there enough evidence available nowadays to suggest a paradigmatic shift in treatment of MIBC with perioperative systemic therapy administration?Francesco Del Giudice, David D'Andrea, Andrea Mari, et al.
Minerva Urology and Nephrology|January 11, 2023
Comment on "Neoadjuvant systemic therapy in patients undergoing nephroureterectomy for urothelial cancer: a multidisciplinary systematic review and critical analysis" on behalf of the Young Academic Urologists - Urothelial Cancer Working GroupLuca Afferi, Andrea Gallioli, Francesco Del Giudice, et al.
Urologia Internationalis|July 24, 2015
Does the Compliance to Intravesical BCG Differ between Common Clinical Practice and International Multicentric Trials?Vincenzo Serretta, Cristina Scalici Gesolfo, Vincenza Alonge, et al.
Current Urology Reports|August 13, 2015
What is the Need for Prostatic Biomarkers in Prostate Cancer Management?Martin Spahn, Silvan Boxler, Steven Joniau, et al.
Pageof 56